EnRhythm(TM) pacemaker and EnTrust(TM) defibrillators now available in Europe Medtronic, Inc. (NYSE:MDT) today announced the European introductions of the Medtronic EnRhythm(TM) pacemaker ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- ...

The cardiac pacemaker harmlessly dissolves over the course of 35 days. (Courtesy: Northwestern University) Temporary cardiac pacemakers provide essential pacing for patients with short-term heart ...

MINERVA Trial Presented at Heart Rhythm Meeting Shows Medtronic Advanced Pacing Features Reduce the Progression of Persistent AF by 58 Percent While Reducing AF-Related Hospital Visits That Lead to ...

Vienna, 30 March 2025– The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of ...

In 2023, the field of heart rhythm saw major developments and continuing evolution of drug and device therapies for patients with atrial fibrillation (AF), as well as additional data bolstering use of ...

This study builds on the growing body of evidence for managing heart failure using the St. Jude Medical MultiPoint pacing technology for patients not responsive to other therapy options ST. PAUL, Minn ...

SUDDEN death in persons with artificial pacemakers is a continuing and disturbing problem. Causes include pacemaker-catheter displacement, electric-component failure, broken wires and rising pacing ...

Having an accelerated junctional rhythm occurs when the atrioventricular node in your heart beats too quickly. It happens as a result of damage to your heart’s primary natural pacemaker. There’s no ...

The U.S. Food and Drug Administration today approved the first pacemaker that does not require the use of wired leads to provide an electrical connection between the pulse-generating device and the ...